Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Abstract The most successful immunotherapies for solid malignancies to date, immune checkpoint inhibitors, target the essential role of T cells in antitumor immunity. However, T‐cell dysfunction presents a major hindrance to treatment efficacy, warranting research into combined treatment strategies...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2025-01-01
|
| Series: | Clinical & Translational Immunology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/cti2.70030 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|